Cited by 30Virology and Viral DiseasesVaccine Coverage and HesitancyBacterial Infections and Vaccines

A randomised single blind trial of a combined mumps measles rubella vaccine to evaluate serological response and reactions in the UK population

Edees, S., Pullan, C.R., Hull, D.·1991·Public Health

Abstract

Four hundred and twenty children were randomly assigned to receive either mumps measles rubella (MMR) vaccine (207) or measles vaccine (213) in a single blind study, to investigate the reactogenicity and serology of the MMR vaccine. There was no significant difference between the number of children developing symptoms after MMR vaccination to those developing symptoms after measles vaccination. Both vaccines are associated with a rash, temperature and restlessness five to thirteen days after vaccination. The serological response to measles vaccine was similar in both groups with 92-6% seroconverting with MMR, and 96-8% with measles. Seroconvertion against mumps and rubella with the MMR vaccine was 88% and 96% respectively. This study confirms the safety and efficacy of the MMR vaccine in a UK population.

Integrity signals

Registry

Crossref · 10.1016/s0033-3506(05)80282-3

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Edees 1991 concluded there was no significant difference between the numbers of children developing symptoms after MMR or measles vaccination.

    “The trial by Edees concluded that there was no significant difference between the numbers of children developing symptoms after MMR or measles vaccination (Edees 1991).”

    From Vaccines for measles, mumps and rubella in children (2012) · cites this paper as Edees 1991

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Edees, S., Pullan, C. R., & Hull, D.
Affiliations
Queen's Medical Centre (GB)
Corresponding author
Edees, S.
Venue
Public Health
Publisher
Elsevier BV
Published
1991-03
Volume
105
Issue
2
Pages
91-97
ISSN
0033-3506 (ISSN-L)
OpenAlex
W2039201985
Cited by
30
References
12
Citations by year
2023: 1 · 2021: 1 · 2020: 1 · 2017: 1 · 2013: 5 · 2012: 2
FWCI
0.35
Type
journal article
Language
en
Open access
closed
Locations
  • Public Health (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
  • Social Sciences › Health › Vaccine Coverage and Hesitancy
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
Keywords
measles vaccine, MMR vaccine, vaccine reactogenicity, seroconversion, vaccine safety, vaccine efficacy, children, mumps, rubella, measles
MeSH terms
Drug Combinations, United Kingdom, Humans, Infant, Measles Vaccine, Mumps Vaccine, Random Allocation, Rubella Vaccine, Measles-Mumps-Rubella Vaccine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review